Circular RNAs: A Promising Biomarker for Endometrial Cancer
- PMID: 33633465
- PMCID: PMC7901565
- DOI: 10.2147/CMAR.S290975
Circular RNAs: A Promising Biomarker for Endometrial Cancer
Abstract
Endometrial cancer (EC) is one of the most common malignant tumors of the female reproductive tract. EC patients have high morbidity and mortality rates and remain an important cause of cancer-related morbidity and mortality worldwide. More and more studies have shown that a large number of non-coding RNAs (such as microRNAs and long non-coding RNAs) are associated with the occurrence of diseases. Circular RNAs (circRNAs) is an endogenous non-coding RNA. It has a unique covalent structure. Many studies in recent years have found circRNAs differential expression in a variety of tumor tissues compared to matched normal tissues. In endometrial carcinoma, there also are multiple circRNAs differentially expressed and therefore circRNAs perhaps can be used as a diagnostic and prognosis biomarkers of EC. In this review, we described the biogenesis, function and characteristics of circRNAs, and the circRNAs with potential influence and clinical significance on the development of EC were summarized. Adenocarcinoma is the most common form of EC, so this review focuses on endometrioid adenocarcinoma.
Keywords: back-splicing; biogenesis; biomarker; circRNA; endometrial cancer; function.
© 2021 Guo et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures





References
-
- Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and Management of Endometrial Cancer. Am Fam Physician. 2016;93:468–474. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources